Form 4: ADC Therapeutics Director Victor Sandor Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Director Victor Sandor sold 6,995 common shares of ADC Therapeutics SA to cover tax withholding obligations related to the vesting and settlement of restricted share units.
Summary
- On June 17, 2024, Victor Sandor, a director of ADC Therapeutics SA, sold 6,995 common shares of the company.
- The sale was executed at a price of $2.89 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted share units.
- Following the transaction, Victor Sandor directly owns 80,886 common shares of ADC Therapeutics SA.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't convey strong positive or negative sentiment regarding the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company directors and officers. This transaction reflects a standard financial planning activity and doesn't necessarily indicate a change in the director's confidence in the company's future prospects.
Stakeholder Impact
- The sale of shares by a director could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of the transaction: Victor Sandor sold 6,995 common shares. |
| 06/18/2024 | Date of signature by Attorney-in-Fact, Lisa Kallebo. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.